Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFα blockers: Safety and immunogenicity
Authors:
- 1 February 2010
- journal article
- clinical trial
- Published by Elsevier in Clinical Immunology
- Vol. 134 (2) , 113-120
Abstract
No abstract availableKeywords
Funding Information
- Sapienza Università di Roma (C26A059989)
This publication has 35 references indexed in Scilit:
- The Effect of Infliximab and Timing of Vaccination on the Humoral Response to Influenza Vaccination in Patients with Rheumatoid Arthritis and Ankylosing SpondylitisSeminars in Arthritis and Rheumatism, 2010
- Vaccines: Vaccination in Patients with Chronic Rheumatic or Autoimmune DiseasesClinical Infectious Diseases, 2008
- Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseasesAutoimmunity Reviews, 2007
- Influenza vaccination in systemic lupus erythematosus: Safe and protective?Autoimmunity Reviews, 2007
- Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritisSafety and immunogenicityVaccine, 2006
- Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNFα blockersAnnals of the Rheumatic Diseases, 2006
- Immunogenicity and Safety of Pneumococcal Vaccination in Patients with Rheumatoid Arthritis or Systemic Lupus ErythematosusClinical Infectious Diseases, 2002
- Vaccination and Autoimmunity—‘vaccinosis’: A Dangerous Liaison?Journal of Autoimmunity, 2000
- Influenza Vaccination in Patients With Rheumatic DiseasesJAMA, 1979
- Disseminated Lupus Erythematosus Occurring among Student Nurses*New England Journal of Medicine, 1948